ViTAA Medical Solutions Inc. (ViTAA) today announced a strategic partnership with The Society for Vascular Surgery (SVhttps://vascular.org/S) to advance evidence, education, and the responsible adoption of quantitative imaging and artificial intelligence in vascular care.
The partnership will support evidence building, best practices, educational resources for SVS members, physicians and trainees on AI validation, interpretation, and clinical limitations. The relationship has the potential to pave the way for additional AI tools and resources for SVS members through the Society in the future.
The partnership creates a framework for the organizations to lead AI-enabled research opportunities involving imaging and clinical outcomes.
Mitchel Benovoy, PhD, Chief Executive Officer at ViTAA Medical said:
The SVS deserves credit for its foresight in embracing advances in AI, digital health, and imaging while helping its members understand and evaluate these technologies through education and practical resources. We’re proud to contribute ViTAA’s experience in quantitative imaging, precision medicine, and AI to that effort. Together, we can advance innovation responsibly, with evidence and patient care at the center.”
Kenneth Slaw, PhD, Executive Director for The Society for Vascular Surgery said:
“This partnership is a big step into the future of vascular health. Highly advanced AI platforms like ViTAA’s have the potential to change how our members care for and manage their patients. We’re delighted to embark on this historic partnership.”
Randy Moore, MD, FACS, FRCSC, Co-Founder & Chief Medical Officer at ViTAA Medical said:
“As a vascular surgeon, I know physicians need tools they can understand, evidence they can assess, and education grounded in clinical practice. This partnership gives us an opportunity to contribute to that work and help keep patient needs at the center as AI becomes part of vascular care.”